Published 4 months ago

Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says

Summary by Ground News

An oral drug made by Pfizer causes a similar amount of weight loss as, and works quicker than, rival Novo Nordisk’s blockbuster injection Ozempic, according to results from a phase two clinical trial released Monday.

More
Filters

15 Articles

All

Left

Center

Right

Reuters

Pfizer's diabetes drug results in similar weight loss levels as Novo's Ozempic

Pfizer Inc's diabetes drug resulted in weight loss similar to that of Novo Nordisk's Ozempic in a mid-stage study testing it in patients with type 2 diabetes, according to data published in a medical journal.

4 months ago·United Kingdom

Read Full Article

CNBC

Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says

Danuglipron, made by Pfizer could offer an advantage as an oral treatment option for weight loss over a frequent injection of Ozempic, made by Novo Nordisk.

4 months ago·United States

Read Full Article

Financial Post

Novo Nordisk says trial of oral weight-loss drug shows significant result

COPENHAGEN -- Novo Nordisk said on Monday a late-stage trial of an oral version of its drug semaglutide for weight loss has shown statistically significant and superior weight loss when compared to a placebo.

4 months ago·Canada

Read Full Article

UOL

Pfizer drug results in weight loss levels similar to those of Ozempic

The diabetes drug from Pfizer resulted in weight loss similar to that of Ozempic, from Novo Nordisk, in an intermediate-phase study conducted on patients with type 2 diabetes, according to data published in a medical journal. Read more (05/22/2023)

4 months ago·Brazil

Read Full Article

Bloomberg

New Weight-Loss Drug Found to Be Effective in Pill Form, Novo Nordisk Says

Novo Nordisk A/S’s weight-loss drug semaglutide, sold as the once-weekly Wegovy shot, was effective as a daily pill in a study.

4 months ago·United States

Read Full Article

MarketWatch

Pfizer shares jump 4% after diabetes drug shows weight-loss results

Pfizer stock was up 4.2% on Monday after a study of its diabetes treatment danuglipron found that a high dose of the drug reduced body weight by more than...

4 months ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year